Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Adverum Biotechnlgs (ADVM)

13.92   1.75 (14.38%) 01-20 22:59
Open: 13.26 Pre. Close: 12.17
High: 14.79 Low: 13.24
Volume: 2,466,851 Market Cap: 1,357M
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, engages in developing gene therapy product candidates to treat ocular and rare diseases. Its pipeline of product candidates includes ADVM-022, an adeno- associated virus (AAV). 7m8-aflibercept for the treatment of wet age-related macular degeneration; ADVM-043, an investigational gene therapy candidate for the treatment of alpha-1 antitrypsin deficiency; and ADVM-053, a preclinical gene therapy product candidate for the treatment of hereditary angioedema. The company has collaboration agreements with Editas Medicine, Inc. to leverage its proprietary AAV vectors for genome editing technologies to treat up to five inherited retinal diseases; and Regeneron Pharmaceuticals, Inc. for the development of up to eight distinct ocular therapeutic targets. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was founded in 2006 and is headquartered in Redwood City, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 14.809 - 14.869 14.869 - 14.926
Low: 13.104 - 13.164 13.164 - 13.222
Close: 13.819 - 13.918 13.918 - 14.012

Technical analysis

as of: 2021-01-20 4:44:04 PM
Overall:       
Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 17.27     One year: 20.18
Support: Support1: 12.17    Support2: 10.55
Resistance: Resistance1: 14.79    Resistance2: 17.27
Pivot: 11.87
Moving Average: MA(5): 12.16     MA(20): 12.02
MA(100): 12.17     MA(250): 14.25
MACD: MACD(12,26): -0.08     Signal(9): -0.25
Stochastic oscillator: %K(14,3): 64.26     %D(3): 54.27
RSI: RSI(14): 61.68
52-week: High: 26.98  Low: 7.36  Change(%): 19.6
Average Vol(K): 3-Month: 101923  10-Days: 102824

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ADVM has closed above the upper band by 29.2%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 1.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 14 Dec 2020
Adverum Biotechnologies Appoints Pharmaceutical Industry Veteran Dawn Svoronos to Board of Directors - GlobeNewswire

Mon, 23 Nov 2020
Adverum Biotechnologies Presents at the Piper Sandler Annual Virtual Healthcare Conference - GlobeNewswire

Sat, 14 Nov 2020
Adverum Biotechnologies Announces Positive Interim Data from Cohorts 1-4 from OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD - GlobeNewswire

Thu, 05 Nov 2020
Adverum Biotechnologies Reports Recent Business Progress and Third Quarter 2020 Financial Results - GlobeNewswire

Tue, 20 Oct 2020
Adverum Biotechnologies to Present New Data from the OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at AAO 2020 Virtual - GlobeNewswire

Tue, 18 Aug 2020
Adverum Biotechnologies Announces Closing of $217 Million Public Offering of Common Stock - GlobeNewswire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 97
Shares Float (M) 67
% Held by Insiders 0.75
% Held by Institutions 96.25
Shares Short (K) 11,810
Shares Short P. Month (K) 13,020

Stock Financials

EPS -1.280
EPS Est This Year -1.260
EPS Est Next Year -1.310
Book Value (p.s.) 4.770
Profit Margin
Operating Margin
Return on Assets (ttm) -17.7
Return on Equity (ttm) -31.4
Qtrly Rev. Growth
Gross Profit (p.s.) -0.412
Sales Per Share
EBITDA (p.s.) -1.003
Qtrly Earnings Growth
Operating Cash Flow (M) -72
Levered Free Cash Flow (M) -63

Stock Valuations

PE Ratio -10.88
PEG Ratio
Price to Book value 2.92
Price to Sales
Price to Cash Flow -18.87

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.